logo
Select company
Select metric
-9910%Net Margin
VS
Market
2
Sector
6
Industry
11
History
-
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Net Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - Net % Historical data
DateNet Income Common StockNet MarginRevenues
6/30/2025$ -49.55M-9910%$ 500K
3/31/2025$ -47.19M0%$ 0
12/31/2024$ -43.25M0%$ 0
6/30/2024$ -36.89M-3384.08%$ 1.09M
12/31/2023$ -29.47M-294.66%$ 10M
6/30/2023$ -32.59M-365.71%$ 8.91M
12/31/2022$ -42.74M0%$ 0
6/30/2022$ -23.15M0%$ 0
12/31/2021$ 15.91M34.9%$ 45.58M
6/30/2021$ -33.65M-73.83%$ 45.58M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) Net % stands at 0%.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average Net % has been -2332.23%.
  • The median Net % for MEREO BIOPHARMA GROUP PLC during this period was -330.19%
  • MEREO BIOPHARMA GROUP PLC reached its highest Net % over the past 5 years at 34.9%.
  • The lowest Net % recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe -9910%

MEREO BIOPHARMA GROUP PLC's Net % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net % Benchmarks
CompanyNet %
CRDF : CARDIFF ONCOLOGY INC -9348.53%ABEO : ABEONA THERAPEUTICS INC 14310.5%HUMA : HUMACYTE INC -7171.27%AVTX : AVALO THERAPEUTICS INC -10479.82%COYA : COYA THERAPEUTICS INC -4803.12%ABVC : ABVC BIOPHARMA INC -781.19%FDMT : 4D MOLECULAR THERAPEUTICS INC -594375.76%VTGN : VISTAGEN THERAPEUTICS INC -8634.67%ERNA : ERNEXA THERAPEUTICS INC -8959.02%ANNX : ANNEXON INC -

Definition of Net Margin

[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Net Inc. Cmn. / Revenues
(=) Net %
Net % for MEREO BIOPHARMA GROUP PLC is calculated as follows: Net Inc. Cmn. [ $ -204.53M ] / Revenues [ $ 0 ]
(=) Net % [ 0% ]

MREO - Net Margin, Last 5 years

-9910%

Minimum

Jun 30, 2025

34.9%

Maximum

Dec 31, 2021

-2332.23%

Average

-330.19%

Median

Net % Benchmark Analysis

The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.77% with a standard deviation of 19.84%.
The following table provides additional summary stats:
Net % in the Market:
filtered constituents3.2K
min-64.23%
max69.74%
average4.77%
median5.25%
std19.84%